Confluent Medical Technologies Acquires Corpus Medical, Combining Advanced Catheter Technology Design and Development with Confluent Medical Manufacturing Capabilities

FREMONT, Calif.–(BUSINESS WIRE)–Confluent Medical Technologies (“Confluent Medical”), a global leader in medical device contract manufacturing, today completed the acquisition of Corpus Medical. Confluent Medical is a contract manufacturer with full scale capabilities to provide high-quality, low cost finished class III medical devices. Confluent’s core capabilities revolve around industry-leading expertise in balloon catheters, delivery systems, introducer ...continue reading

Letter to Our Customers: Confluent Medical Technologies to Change Legal Name on January 3, 2017

With the acquisition by Nitinol Devices and Components, Inc. of Interface Associates, Inc. in August of 2015 and the subsequent acquisition earlier this year of ETE Medical, LLC, Modified Polymer Components, Inc., and Biomedical Structures, LLC, our combined companies are moving forward to build on our strong reputations and combining into a unified and more ...continue reading

CONFLUENT MEDICAL TECHNOLOGIES PROVIDES $100,000 GIFT TO COLORADO SCHOOL OF MINES TO ADVANCE ADDITIVE MANUFACTURING

FREMONT, Calif.–(BUSINESS WIRE)–Confluent Medical Technologies (“Confluent Medical”) is partnering with the Colorado School of Mines (“Mines”) and the Alliance for the Development of Additive Processing Technologies (“ADAPT”) program to advance additive manufacturing methods. Confluent Medical Technologies has established the Confluent Medical Postdoctoral Fellowship at Mines toward developing these technologies via an initial $100,000 gift. The ...continue reading

Confluent Medical Technologies Acquires Biomedical Structures and Modified Polymer Components; Combining Nitinol and Catheter Capabilities With Implantable Textiles and Precision Polymers Capabilities

FREMONT, Calif.–(BUSINESS WIRE)–Confluent Medical Technologies (“Confluent Medical”) today completed the acquisition of ETE Medical and its operating subsidiaries Biomedical Structures (“BMS”) and Modified Polymer Components (“MPC”). Confluent Medical itself was formed in 2015 through the acquisition of Interface Catheter Solutions by Nitinol Devices and Components. BMS specializes in the development and manufacturing of biomedical textile ...continue reading

NITINOL DEVICES & COMPONENTS ACQUIRES INTERFACE CATHETER SOLUTIONS TO CREATE CONFLUENT MEDICAL TECHNOLOGIES

  Tags: ,
FREMONT, Calif.–(BUSINESS WIRE)–Nitinol Devices & Components, Inc. (“NDC”), announced today it has successfully completed the acquisition of Interface Catheter Solutions (“Interface”). Reflecting the combination’s expanded strategic breadth, NDC and Interface will create Confluent Medical Technologies (“Confluent Medical”), the leading contract manufacturer of specialized medical devices. The combined company will leverage the technical expertise of both ...continue reading

MARK LEMMA JOINS NDC

  Tags:
Nitinol Devices & Components (“NDC”) is pleased to announce that Mark Lemma has joined the company as Chief Financial Officer. Mark comes to NDC with more than 25 years of financial, operational and administrative leadership across a variety of industries and geographies. Most recently, Mark served as Chief Financial Officer of Speculative Product Design, LLC ...continue reading

DAVID JOHNSTON JOINS NDC

  Tags:
Nitinol Devices & Components (“NDC”) is pleased to announce that David Johnston has joined our team as Vice President, Costa Rica Operations.  David comes to NDC with more than 20 years of medical product operations, supply chain and manufacturing experience including work at companies that include VertiSync LLC, Accellent, and Arthur Anderson Business Consulting. Most ...continue reading

NDC LAUNCHES NEW BRAND STRATEGY

  Tags:
Today Nitinol Devices & Components (“NDC”) launched a new corporate brand strategy that elevates the company’s corporate identity and underscores its unique abilities to support medical device manufacturers from concept generation to commercial scale production. The new strategy emphasizes NDC’s specific capabilities and expertise in working with Nitinol-based devices for endovascular, peripheral vascular, cardiovascular, neurovascular ...continue reading

INTERFACE CATHETER SOLUTIONS ANNOUNCES MEDICALBALLOONEXPERTS.COM EDUCATIONAL BLOG

  Tags:
Laguna Niguel, CA – August, 20, 2013 – Each blog post will include content on key balloon development and manufacturing insights, analysis and white papers from technical experts on design, manufacturing, quality and balloon forming equipment.   Balloon design and manufacturing is a complex science that requires a mastery of material behavior, balloon forming technology, and ...continue reading

NDC APPOINTS DEAN SCHAUER AS PRESIDENT AND CEO

  Tags:
Nitinol Devices & Components (NDC) today announced the appointment of Dean Schauer as its President and CEO, effective September 1, 2013. “We are delighted to welcome someone as singularly qualified as Dean to take NDC to the next stage of its development,” said Tom Duerig, current President and CEO. “Dean is an experienced senior executive ...continue reading